Literature DB >> 23351297

Informed consent for off-label use of prescription medications.

Zain Mithani1.   

Abstract

Mesh：

Year:  2012        PMID： 23351297     DOI： 10.1001/virtualmentor.2012.14.7.oped1-1207

Source DB:  PubMed          Journal:  Virtual Mentor        ISSN： 1937-7010


× No keyword cloud information.
  4 in total

Review 1.  Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions : Comparative regulation framework of off label prescriptions in pediatrics: a review.

Authors:  Benedetta Guidi; Andrea Parziale; Luca Nocco; Aniello Maiese; Raffaele La Russa; Marco Di Paolo; Emanuela Turillazzi
Journal:  Int J Clin Pharm       Date:  2021-09-08

Review 2.  Use of contrast media in diagnostic imaging: medico-legal considerations.

Authors:  C Pomara; N Pascale; F Maglietta; M Neri; I Riezzo; E Turillazzi
Journal:  Radiol Med       Date:  2015-06-17       Impact factor: 3.469

3.  Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework.

Authors:  Doah Cho; Sarah J Lord; John Simes; Wendy Cooper; Michael Friedlander; Susie Bae; Chee Khoon Lee
Journal:  Ther Adv Med Oncol       Date:  2022-07-29       Impact factor: 5.485

4.  Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study.

Authors:  Sadia Shakeel; Shagufta Nesar; Hina Rehman; Khizra Jamil; Imran Ahsan Mallick; Muhammad Shahid Mustafa; Mudassir Anwar; Shazia Jamshed
Journal:  Pharmacy (Basel)       Date:  2021-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.